FrancophonIA/ELRC3.0 huggingface dataset:
English: Avibactam does not inhibit class B enzymes (metallo-β-lactamases) and is not able to inhibit many of the class D enzymes (see section
Croatian: Avibaktam ne inhibira enzime klase B (metalo-beta-laktamaze) i ne može inhibirati mnoge enzime klase D (vidjeti dio 5.1).
English: Do not insert a gas relief needle until the product has dissolved.
Croatian: 3. Nemojte uvoditi iglu za odvod plina dok se lijek ne otopi.
English: Efficacy has been demonstrated in clinical studies against the following pathogens that were susceptible to ceftazidime/avibactam in vitro.
Croatian: U kliničkim je ispitivanjima dokazana djelotvornost protiv sljedećih patogena koji su bili osjetljivi na ceftazidim-avibaktam in vitro.
English: For avibactam the PK-PD index is the percent time of the free drug concentration above a threshold concentration over the dose interval (% fT >CT).
Croatian: Za avibaktam je indeks farmakokinetičkog/farmakodinamičkog odnosa postotak vremena tijekom intervala doziranja u kojem je koncentracija nevezanog lijeka iznad granične koncentracije (%fT > CT).
English: Appropriate infusion diluents include: sodium chloride 9 mg/mL (0.9%) solution for injection, dextrose 50 mg/mL (5%) solution for injection, sodium chloride 4.5 mg/mL and dextrose 25 mg/mL solution for injection (0.45% sodium chloride and 2.5% dextrose) or Lactated Ringer's solution.
Croatian: Prikladna sredstva za razrjeđivanje infuzije uključuju: otopinu natrijevog klorida 9 mg/ml (0,9%) za injekciju, otopinu glukoze 50 mg/ml (5%) za injekciju, otopinu natrijevog klorida 4,5 mg/ml i glukoze 25 mg/ml za injekciju (0,45% natrijevog klorida i 2,5% glukoze) ili otopinu Ringerovog laktata.
English: METHOD AND ROUTE(S) OF ADMINISTRATION
Croatian: NAČIN I PUT(EVI) PRIMJENE
English: Complicated intra-abdominal infections Gram-negative micro-organisms
Croatian: Komplicirane intraabdominalne infekcije Gram-negativni mikroorganizmi
English: Unchanged avibactam was the major drug-related component in human plasma and urine following dosing with [
Croatian: C]avibaktama, glavna sastavnica povezana s lijekom u ljudskoj plazmi i urinu bio je avibaktam u nepromijenjenom obliku.
English: Table 1 Recommended intravenous dose for patients with estimated CrCL ≥ 51 mL/min Type of infection
Croatian: Tablica 1 Preporučene intravenske doze za bolesnike s procijenjenim CrCl ≥ 51 ml/min Vrsta infekcije
English: It is unknown whether avibactam is excreted in human milk.
Croatian: Nije poznato izlučuje li se avibaktam u majčino mlijeko.
English: The following side effects may happen with this medicine:
Croatian: Kod primjene ovog lijeka mogu se javiti sljedeće nuspojave:
English: • decrease in the number of red blood cells (haemolytic anaemia) - shown in blood tests
Croatian: • smanjen broj crvenih krvnih stanica (hemolitička anemija) - vidi se u nalazima krvnih pretraga
English: 0.75 g/0.1875 g Every 48 hours
Croatian: 0,75 g/0,1875 g
English: No dosage adjustment is required in patients with mild renal impairment (estimated CrCL ≥ 51≤ 80 mL/min) (see section 5.2).
Croatian: Nije potrebno prilagođavati dozu u bolesnika s blagim oštećenjem bubrega (procijenjeni CrCl ≥ 51≤ 80 ml/min) (vidjeti dio 5.2).
English: Concurrent treatment with high doses of cephalosporins and nephrotoxic medicinal products such as aminoglycosides or potent diuretics (e.g. furosemide) may adversely affect renal function.
Croatian: Istodobno liječenje visokim dozama cefalosporina i nefrotoksičnih lijekova poput aminoglikozida ili potentnih diuretika (npr. furosemida) može štetno utjecati na bubrežnu funkciju.
English: • infections of the bladder or kidneys called “urinary tract infections”
Croatian: • infekcija mokraćnog mjehura ili bubrega, koje se zovu "infekcije mokraćnog sustava"
English: Ceftazidime and avibactam are eliminated via the kidneys, therefore, the dose should be reduced according to the degree of renal impairment (see section 4.2).
Croatian: Budući da se ceftazidim i avibaktam eliminiraju putem bubrega, njihovu dozu treba smanjiti sukladno stupnju oštećenja bubrega (vidjeti dio 4.2).
English: Concurrent treatment with high doses of cephalosporins and nephrotoxic medicinal products such as aminoglycosides or potent diuretics (e.g. furosemide) may adversely affect renal function (see section 4.4).
Croatian: Istodobno liječenje visokim dozama cefalosporina i nefrotoksičnih lijekova poput aminoglikozida ili potentnih diuretika (npr. furosemida) može štetno utjecati na bubrežnu funkciju (vidjeti dio 4.4).
English: An infusion bag may contain any of the following: sodium chloride 9 mg/mL (0.9%) solution for injection, dextrose 50 mg/mL (5%) solution for injection, sodium chloride 4.5 mg/mL and dextrose 25 mg/mL solution for injection (0.45% sodium chloride and 2.5% dextrose) or Lactated Ringer's solution.
Croatian: Infuzijska vrećica može sadržavati bilo koju od sljedećih otopina: otopinu natrijevog klorida 9 mg/ml (0,9%) za injekciju, otopinu glukoze 50 mg/ml (5%) za injekciju, otopinu natrijevog klorida 4,5 mg/ml i glukoze 25 mg/ml za injekciju (0,45% natrijevog klorida i 2,5% glukoze) ili otopinu Ringerovog laktata.
English: • Complicated urinary tract infection (cUTI), including pyelonephritis
Croatian: • komplicirane infekcije mokraćnog sustava, uključujući pijelonefritis
English: Complicated intra-abdominal infections
Croatian: Komplicirane intraabdominalne infekcije
English: Clostridium difficile colitis
Croatian: Proljev povezan s Clostridium difficile
English: The pharmacokinetics of avibactam in patients with any degree of hepatic impairment has not been studied.
Croatian: Farmakokinetika avibaktama u bolesnika s bilo kojim stupnjem oštećenja jetre nije ustanovljena.
English: Hospital-acquired pneumonia including ventilator-associated pneumonia Gram-negative micro-organisms
Croatian: Bolnička pneumonija, uključujući pneumoniju povezanu s mehaničkom ventilacijom Gram-negativni mikroorganizmi
English: In-vitro data indicate that the following species are not susceptible to ceftazidime/avibactam.
Croatian: Podaci iz ispitivanja in vitro pokazuju da sljedeće vrste nisu osjetljive na ceftazidim/avibaktam:
English: The average increases in avibactam AUC are 3.8-fold and 7-fold in subjects with moderate and severe renal impairment, see section 4.2.
Croatian: Prosječno povećanje AUC-a avibaktama u ispitanika s umjerenim i teškim oštećenjem bubrega je za 3,8 puta i za 7 puta, vidjeti dio 4.2.
English: Dry powder
Croatian: Suhi prašak:
English: For storage conditions of the reconstituted and diluted medicinal product, see section 6.3.
Croatian: Uvjete čuvanja nakon rekonstitucije i razrjeđivanja lijeka vidjeti u dijelu 6.3.
English: Tell your doctor or nurse if you notice any of the side effects listed above.
Croatian: Obratite se svom liječniku ili medicinskoj sestri ako primijetite bilo koju od gore navedenih nuspojava.
English: Table 3 Frequency of adverse reactions by system organ class
Croatian: Tablica 3 Učestalost nuspojava prema organskim sustavima
English: Resistance
Croatian: Rezistencija
English: • a water tablet called furosemide
Croatian: • tabletu za izmokravanje, a zove se furosemid
English: Other medicines and Zavicefta Tell your doctor or nurse if you are using, have recently used or might use any other medicines.
Croatian: Obavijestite svog liječnika ili medicinsku sestru ako primjenjujete, nedavno ste primijenili ili biste mogli primijeniti bilo koje druge lijekove.
English: Aseptic technique must be followed in preparing the infusion solution.
Croatian: Kod pripreme otopine za infuziju mora se primjenjivati aseptična tehnika.
English: After dilution
Croatian: Nakon razrjeđivanja:
English: oC.
Croatian: A.
English: • raised itchy skin rash (“hives”)
Croatian: • izdignut kožni osip koji svrbi ("koprivnjača")
English: • an increase in the level of some types of substances in your blood (called “creatinine” and
Croatian: • povećana razina nekih tvari u krvi (koje se zovu "kreatinin" i "urea").
English: • significant decrease in the type of white blood cells used to fight infection - shown in blood tests
Croatian: • značajno smanjen broj jedne vrste bijelih krvnih stanica koje se bore protiv infekcija vidi se u nalazima krvnih pretraga
English: Table 2 shows the recommended dose adjustments for patients with estimated CrCL ≤ 50 mL/min (see sections 4.4 and 5.2).
Croatian: U tablici 2 prikazane su preporučene prilagodbe doza za bolesnike s procijenjenim CrCl od ≤ 50 ml/min (vidjeti dijelove 4.4 i 5.2).
English: No synergy or antagonism was demonstrated in in vitro drug combination studies with ceftazidime/avibactam and metronidazole, tobramycin, levofloxacin, vancomycin, linezolid, colistin and tigecycline.
Croatian: Ispitivanja in vitro kombinacije ceftazidima/avibaktama i metronidazola, tobramicina, levofloksacina, vankomicina, linezolida, kolistina i tigeciklina nisu pokazala sinergističko niti antagonističko djelovanje.
English: If you miss a dose of Zavicefta If you think you have missed a dose, tell your doctor or nurse straight away.
Croatian: Ako mislite da ste propustili dozu lijeka Zavicefta, odmah o tome obavijestite svog liječnika ili medicinsku sestru.
English: This medicinal product does not require any special storage conditions.
Croatian: Nema posebnih uvjeta čuvanja.
English: This is because you may get an abnormal result with a test called “DAGT” or “Coombs”.
Croatian: Naime, može doći do odstupanja u nalazima pretrage koja se zove "DAGT" ili "Coombsov test".
English: Table 1 shows the recommended intravenous dose for patients with estimated creatinine clearance (CrCL) ≥ 51 mL/min (see sections 4.4 and 5.1).
Croatian: U tablici 1 prikazane su preporučene intravenske doze za bolesnike kojima je procijenjeni klirens kreatinina (CrCl) ≥ 51 ml/min (vidjeti dijelove 4.4 i 5.1).
English: The mean elimination half-life of ceftazidime ranged from 3.5 to 4 hours following intravenous bolus dosing with 2 g every 12 hours in elderly patients aged 80 years or older.
Croatian: Srednja vrijednost poluvijeka eliminacije ceftazidima u starijih bolesnika u dobi od 80 ili više godina iznosila je između 3,5 i 4 sata nakon intravenskih bolusnih injekcija doze od 2 g svakih 12 sati.
English: Dose of ceftazidime/avibactam
Croatian: Doza ceftazidima/avibaktama
English: Undesirable effects may occur (e.g. dizziness), which may influence the ability to drive and use machines following administration of Zavicefta (see section 4.8).
Croatian: Nakon primjene lijeka Zavicefta mogu se javiti nuspojave (npr. omaglica) koje mogu utjecati na sposobnost upravljanja vozilima i rada sa strojevima (vidjeti dio 4.8).
English: Avibactam
Croatian: Avibaktam
English: Zavicefta contains sodium
Croatian: Zavicefta sadrži natrij
English: Avibactam showed no significant inhibition of cytochrome P450 enzymes in vitro.
Croatian: Avibaktam nije pokazao značajnu inhibiciju enzima citokroma
English: Resistant
Croatian: Rezistentan
English: The maximum daily dose of this product is equivalent to 22.2% of the WHO recommended maximum daily intake for sodium.
Croatian: Maksimalna dnevna doza lijeka odgovara 22,2% maksimalnog dnevnog unosa od 2 g natrija prema preporukama SZO za odraslu osobu.
English: Each vial contains a total of 6.44 mmol of sodium (approximately 148 mg), equivalent to 7.4% of the WHO recommended maximum daily intake for sodium.
Croatian: Prilikom primjene lijeka Zavicefta u bolesnika koji su na dijeti s kontroliranim unosom natrija mora se uzeti u obzir da jedna bočica sadrži ukupno 6,44 mmol (približno 148 mg) natrija, što odgovara 7,4% maksimalnog dnevnog unosa od 2 g natrija prema preporukama SZO za odraslu osobu.
English: Clostridium difficile-associated diarrhoea has been reported with ceftazidime/avibactam, and can range in severity from mild to life-threatening.
Croatian: Kod primjene ceftazidima/avibaktama prijavljen je proljev povezan s Clostridium difficile, čija se težina može kretati od blage do opasne po život.
English: Ceftazidime crosses the placenta readily, and is excreted in the breast milk.
Croatian: Ceftazidim s lakoćom prolazi kroz posteljicu i izlučuje se u majčino mlijeko.
English: Approximately 97% of the avibactam dose is recovered in the urine, 95% within 12 h. Less than 1% of ceftazidime is excreted via the bile and less than 0.25% of avibactam is excreted into faeces.
Croatian: Manje od 1% ceftazidima izlučuje se putem žuči, a manje od 0,25% avibaktama u feces.
English: How to store Zavicefta
Croatian: Kako čuvati lijek Zavicefta
English: Very common
Croatian: Vrlo često Često
English: Table 2 Recommended intravenous doses for patients with estimated CrCL ≤ 50 mL/min Estimated CrCL (mL/min)
Croatian: Tablica 2 Preporučene intravenske doze u bolesnika s procijenjenim CrCl od ≤ 50 ml/min Procijenjeni CrCl (ml/min)
English: Spectrum of activity of ceftazidime/avibactam
Croatian: Spektar djelovanja ceftazidima/avibaktama
English: Hepatic impairment No dosage adjustment is required in patients with hepatic impairment (see section 5.2).
Croatian: Nije potrebno prilagođavati dozu u bolesnika s oštećenjem jetre (vidjeti dio 5.2).
English: What Zavicefta looks like and contents of the pack Zavicefta is a white to yellow powder for concentrate for solution for infusion in a vial.
Croatian: Zavicefta je bijeli do žuti prašak za koncentrat za otopinu za infuziju u bočici.
English: Dosing of Zavicefta on haemodialysis days should occur after completion of haemodialysis.
Croatian: Doza lijeka Zavicefta se na dane kada se provodi hemodijaliza treba primijeniti nakon završetka hemodijalize.
English: Patients experiencing anaemia during or after treatment with Zavicefta should be investigated for this possibility.
Croatian: Tu mogućnost treba ispitati u bolesnika koji razviju anemiju tijekom ili nakon liječenja lijekom Zavicefta.
English: A total of 81 cUTI patients (7.4%) had bacteraemia at baseline.
Croatian: Ukupno je 81 (7,4%) bolesnik s kompliciranom infekcijom mokraćnog sustava imao bakterijemiju na početku ispitivanja.
English: No appreciable accumulation of ceftazidime or avibactam was observed following multiple intravenous infusions of 2000 mg/500 mg of ceftazidime/avibactam administered every 8 hours for up to 11 days in healthy adults with normal renal function.
Croatian: Nakon višestrukih intravenskih infuzija ceftazidima/avibaktama u dozi od 2000 mg/500 mg, primijenjenih zdravim odraslim osobama s normalnom bubrežnom funkcijom svakih 8 sati tijekom najviše 11 dana, nije primijećena značajna kumulacija ceftazidima ni avibaktama.
English: Vulvovaginal candidiasis and Oral candidiasis)
Croatian: Infekcije i infestacije kandidijaza (uključujući vulvovaginalnu kandidijazu i oralnu kandidijazu)
English: • The active substances are ceftazidime and avibactam.
Croatian: • Djelatne tvari su ceftazidim i avibaktam.
English: • decrease in the number of some types of blood cells (called “leucocytes”) - shown in blood tests
Croatian: • smanjen broj nekih vrsta krvnih stanica (koje se zovu "leukociti") - vidi se u nalazima krvnih pretraga
English: • tingling or numbness
Croatian: • trnci ili utrnulost
English: Uncommon: (may affect up to 1 in 100 people)
Croatian: Manje često: (mogu se javiti u manje od 1 na 100 osoba)
English: How to use Zavicefta
Croatian: Kako primjenjivati lijek Zavicefta
English: Standard aseptic techniques should be used for solution preparation and administration.
Croatian: Kod pripreme i primjene otopine moraju se primijeniti standardne aseptične tehnike.
English: Common: (may affect up to 1 in 10 people)
Croatian: Često: (mogu se javiti u manje od 1 na 10 osoba)
English: The reconstituted solution is pale yellow solution and free of particles.
Croatian: Rekonstituirana otopina je blijedožuta otopina koja ne sadrži čestice.
English: Skin and subcutaneous tissue disorders
Croatian: Poremećaji kože i potkožnog tkiva makulopapularni osip urtikarija pruritus toksična epidermalna nekroliza
English: The steady-state volumes of distribution of ceftazidime and avibactam were about 22 L and 18 L, respectively in healthy adults following multiple doses of 2000 mg/500 mg ceftazidime/avibactam infused over 2 hours every 8 hours.
Croatian: Nakon višestrukih doza ceftazidima/avibaktama od 2000 mg/500 mg primijenjenih infuzijom zdravim odraslim osobama tijekom 2 sata svakih 8 sati, volumen distribucije u stanju dinamičke ravnoteže za ceftazidim i avibaktam iznosio je 22 l odnosno 18 l.
English: Withdraw the needle and shake the vial to give a clear solution.
Croatian: 2. Izvucite iglu i protresite bočicu kako biste dobili bistru otopinu.
English: Each vial contains ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam.
Croatian: Jedna bočica sadrži 2 g ceftazidima u obliku ceftazidim pentahidrata te 0,5 g avibaktama u obliku avibaktamnatrija.
English: • fever
Croatian: • vrućica
English: Important: Please refer to the Summary of Product Characteristics before prescribing.
Croatian: Važno: Prije nego što propišete lijek, pročitajte sažetak opisa svojstava lijeka.
English: Neurological sequelae, including tremor, myoclonus, non-convulsive status epilepticus, convulsion, encephalopathy and coma, have occasionally been reported with ceftazidime when the dose has not been reduced in patients with renal impairment.
Croatian: Kada se u bolesnika s oštećenjem bubrega nije smanjila doza ceftazidima, povremeno su prijavljene neurološke posljedice, uključujući tremor, mioklonus, nekonvulzivni epileptički status, konvulzije, encefalopatiju i komu.
English: • Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP)
Croatian: • bolnička pneumonija, uključujući pneumoniju povezanu s mehaničkom ventilacijom
English: Ceftazidime is excreted unchanged into the urine by glomerular filtration; approximately 80-90% of the dose is recovered in the urine within 24 h. Avibactam is excreted unchanged into the urine with a renal clearance of approximately 158 mL/min, suggesting active tubular secretion in addition to glomerular filtration.
Croatian: Ceftazidim se u neizmijenjenom obliku izlučuje u urin glomerularnom filtracijom; približno 80 - 90% doze pronalazi se u urinu unutar 24 sata.
English: Zavicefta 2 g/0.5 g powder for concentrate for solution for infusion
Croatian: Zavicefta 2 g/0,5 g prašak za koncentrat za otopinu za infuziju
English: Dosage strength ceftazidime/avibactam (mg)
Croatian: Jačina doze ceftazidima/avibaktama (mg)
English: • increase in the number of a type of blood cell (called “lymphocytes”) - shown in blood tests
Croatian: • povećan broj jedne vrste krvnih stanica (koje se zovu "limfociti") - vidi se u nalazima krvnih pretraga
English: Avibactam and ceftazidime showed no in vitro cytochrome P450 induction at clinically relevant concentrations.
Croatian: Avibaktam i ceftazidim nisu pokazali indukciju citokroma
English: Complicated urinary-tract infections Gram-negative micro-organisms
Croatian: Komplicirane infekcije mokraćnog sustava Gram-negativni mikroorganizmi
English: Zavicefta will be given to you by a doctor or a nurse, so it is unlikely you will be given the wrong dose.
Croatian: Ako primite više lijeka Zavicefta nego što ste trebali Budući da će Vam lijek Zavicefta dati liječnik ili medicinska sestra, nije vjerojatno da ćete primiti pogrešnu dozu.
English: What Zavicefta is
Croatian: Što je Zavicefta
English: Drug Reaction with Eosinophilia and Systemic Symptoms)
Croatian: Stevens-Johnsonov sindrom multiformni eritem angioedem reakcija na lijek s eozinofilijom i sistemskim simptomima (DRESS)
English: • change in the number of some types of blood cells (called “eosinophils” and “thrombocytes”)
Croatian: • promjena u broju nekih vrsta krvnih stanica (koje se zovu "eozinofili" i "trombociti") - vidi se u nalazima krvnih pretraga
English: Τηλ.
Croatian: Tel.
English: Complicated UTI, including pyelonephritis
Croatian: Komplicirana infekcija mokraćnog sustava, uključujući pijelonefritis
English: VIAL LABEL
Croatian: NALJEPNICA BOČICE
English: Nervous system disorders
Croatian: Poremećaji živčanog sustava glavobolja omaglica parestezija
English: Haemolytic anaemia
Croatian: • anaerobne bakterije
English: In patients with renal impairment, close monitoring of estimated creatinine clearance is advised.
Croatian: Savjetuje se pažljivo praćenje procijenjenog klirensa kreatinina u bolesnika s oštećenom bubrega.
English: Пфайзер Люксембург САРЛ, Клон България Тел.
Croatian: Pfizer Luxembourg SARL filialas Lietuvoje Tel.
English: Clinical efficacy and safety studies of Zavicefta have been conducted in cIAI, cUTI and HAP (including VAP).
Croatian: Klinička ispitivanja djelotvornosti i sigurnosti lijeka Zavicefta provedena su kod kompliciranih intraabdominalnih infekcija, kompliciranih infekcija mokraćnog sustava i bolničkih pneumonija (uključujući pneumonije povezane s mehaničkom ventilacijom).
English: ITALY
Croatian: ITALIJA
English: Urticaria
Croatian: Doziranje
English: Tel: + 385 1 3908 777
Croatian: Pfizer Croatia d.o.o. Tel: + 385 1 3908 777
English: Complicated urinary tract infections
Croatian: Komplicirane infekcije mokraćnog sustava
English: Jaundice
Croatian: Učestalost
English: Hospital-acquired pneumonia, including VAP
Croatian: Bolnička pneumonija, uključujući pneumoniju povezanu s mehaničkom ventilacijom
English: Ceftazidime concentrations of 4 to 20 mg/L or more are achieved in the CSF when the meninges are inflamed.
Croatian: Kada su moždane ovojnice upaljene, u cerebrospinalnom likvoru postižu se koncentracije ceftazidima od 4 do 20 mg/l ili više.
English: B.PACKAGE LEAFLET
Croatian: Tablični prikaz nuspojava
English: • Complicated intra-abdominal infection (cIAI)
Croatian: • komplicirane intraabdominalne infekcije
English: ZAVICEFTA 2 g/0.5g powder for concentrate for solution for infusion ceftazidime/avibactam
Croatian: ZAVICEFTA 2 g/0,5 g prašak za koncentrat za otopinu za infuziju ceftazidim/avibaktam
English: Zavicefta 2 g/0.5 g powder for concentrate for solution for infusion ceftazidime/avibactam
Croatian: Zavicefta 2 g/0,5 g prašak za koncentrat za otopinu za infuziju ceftazidim/avibaktam
English: • Anaerobes
Croatian: • omaglica
English: Blood and lymphatic system disorders
Croatian: Poremećaji imunološkog sustava anafilaktička reakcija
English: Sodium carbonate (anhydrous)
Croatian: 6.1 Popis pomoćnih tvari natrijev karbonat (bezvodni)
English: Driving and using machines Zavicefta may make you feel dizzy.
Croatian: Zavicefta može uzrokovati omaglicu.
English: This is because Zavicefta is removed from your body by the kidneys.
Croatian: Naime, Zavicefta se iz tijela uklanja putem bubrega.
English: ZAVICEFTA 2 g/0.5 g powder for concentrate ceftazidime/avibactam
Croatian: ZAVICEFTA 2 g/0,5 g prašak za koncentrat ceftazidim/avibaktam i.v.
English: IV
Croatian: B.
English: • feeling sick (nausea) or being sick (vomiting)
Croatian: • mučnina ili povraćanje
English: Dose regimen
Croatian: Režim doziranja
English: • itchiness
Croatian: • proljev
English: Vivian Corporation Ltd. Tel: +35621 344610
Croatian: Tel: +35621 344610
English: People with kidney problems
Croatian: Osobe s bubrežnim tegobama
English: Posology
Croatian: KUTIJA
English: Tell your doctor that you are taking Zavicefta if you are going to have any tests.
Croatian: Ako morate napraviti bilo kakve pretrage, recite svom liječniku da primate lijek Zavicefta.
English: Infections and infestations
Croatian: Infekcije uzrokovane aerobnim
English: Toxic epidermal necrolysis
Croatian: Nefrotoksičnost
English: shown in blood tests
Croatian: Granične vrijednosti testova osjetljivosti
English: Acute kidney injury
Croatian: Oštećenje bubrega
English: Dizziness
Croatian: Osjetljiv
English: Take the next capsule at the usual time.
Croatian: Uzmite slijedeću kapsulu u uobičajeno vrijeme.
English: You should swallow the whole capsule with a glass of water.
Croatian: Trebate progutati cijelu kapsulu s čašom vode.
English: Always take this medicine exactly as your doctor has told you.
Croatian: Uvijek uzmite ovaj lijek točno onako kako Vam je rekao liječnik.
English: The average half-life is 6-7 hours.
Croatian: Prosječni poluvijek je 6 - 7 sati.
English: Your doctor can give you more information.
Croatian: Liječnik će Vam dati više informacija.
English: Ask your pharmacist how to throw away medicines you no longer take.
Croatian: Pitajte svog ljekarnika kako baciti lijekove koje više ne koristite.